Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial Comparing Treatment With Melphalan+Prednisolon (MP) With Melphalan+Prednisolon+Thalidomide (MPT) for Previously Untreated Elderly Patients With Multiple Myeloma

NCT00934154 is registered in ClinicalTrials.gov with Cigdem Sahinbas YILMAZ as lead sponsor.

NCT NCT00934154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00934154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial Comparing Treatment With Melphalan+Prednisolon (MP) With Melphalan+Prednisolon+Thalidomide (MPT) for Previously Untreated Elderly Patients With Multiple Myeloma
Lead sponsor
Cigdem Sahinbas YILMAZ
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
September 30, 2012
Enrollment
122 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma